focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Regulatory News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

7 Mar 2016 07:00

RNS Number : 1800R
ABCAM Plc
07 March 2016
 

7 March 2016

 

ABCAM PLC

 

("Abcam" or "the Company")

 

Directorate Change

 

Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, announces that after fifteen years at Abcam, Jim Warwick has today served notice of his intention to retire from Abcam and step down from the Board by the end of 2016. Jim remains committed to the Company and will continue to work with the executive team to lead existing activities and plan the transition of his role. Over his time with Abcam Jim has had a variety of roles and most recently as Chief Operating Officer (COO) he has led Innovation & Manufacturing, IT, Operations and Human Resources (HR) activity. Jim's role as COO will not be replaced. Instead the business will be restructured with IT, Operations and HR each joining the Chief Executive Officer's direct reports.

 

Alan Hirzel, CEO of Abcam, said:

 

"Jim has played a key role in Abcam's journey and has shaped a large part of our success. We will work with him on how we manage his portfolio of work and setting up the business with new key roles to support our next phase of growth and change. We have recently appointed Nick Skinner as our Global Human Resources Director, and he has already commenced a search for a Chief Information Officer and will shortly initiate the search for a Global Supply Chain Operations Leader. Jim will lead the rollout of our new technology platform and will be working with us until the end of 2016; a reflection of his commitment to the business."

 

Jim Warwick, COO, said:

 

"Over the last fifteen years it has been a privilege to be a part of the Abcam journey. Seeing the tremendous success and growth of the business into a global market leader is humbling. I remain committed to the business and excited about continuing to lead the rollout of our new technology platforms."

 

For further information please contact:

 

Abcam

+ 44 (0) 1223 696 000

Alan Hirzel, Chief Executive Officer

Jeff Iliffe, Chief Financial Officer

Julia Wilson - Investor Relations

 

 

J.P.Morgan Cazenove - Nominated Advisor & Corporate Broker

+ 44 (0) 20 7742 4000

James Mitford / Alex Bruce

 

 

 

FTI Consulting

+ 44 (0) 20 3727 1000

Ben Atwell / Brett Pollard / Natalie Garland-Collins

 

 

Notes for editors:

 

About Abcam plc

As an innovator in reagents and tools, Abcam's purpose is to serve life science researchers globally to achieve their mission, faster. Providing the research and clinical communities with tools and scientific support, the Company offers highly validated biological binders and assays to address important targets in critical biological pathways.

 

Already a pioneer in data sharing and ecommerce in the life sciences, Abcam's ambition is to be the most influential company in life sciences by helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health. Two-thirds of the world's 750,000 life science researchers use Abcam's affinity binders, reagents, biomarkers and assays and the Company's products are mentioned in over 20,000 of the 56,000 peer-reviewed papers published each year in the life sciences.

 

By actively listening to and collaborating with researchers, the Company continuously advances its portfolio to address their needs. A transparent programme of customer reviews and datasheets, combined with an industry-leading validation initiative, gives researchers increased confidence in their results.

 

Abcam's ten offices are located in the world's leading life science research hubs, enabling local services and multi-language support. Founded in 1998 and headquartered in Cambridge, UK, the Company sells to more than 100 countries. Abcam was admitted to AIM in 2005 (AIM: ABC).

 

To find out more, please visit www.abcam.com and www.abcamplc.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAMMGGFLVMGVZM
Date   Source Headline
6th Mar 201211:02 amRNSHolding(s) in Company
5th Mar 20127:01 amRNSAcquisition
5th Mar 20127:01 amRNSAcquisition
5th Mar 20127:00 amRNSHalf Year Results
28th Feb 20122:06 pmRNSHolding(s) in Company
27th Feb 20122:14 pmRNSPDMR Shareholding
21st Feb 20127:00 amRNSNotice of Interim Results
1st Feb 201210:52 amRNSTotal Voting Rights
31st Jan 20129:19 amRNSPDMR Shareholding
16th Jan 20127:00 amRNSHalf Year Trading Update
29th Dec 20117:00 amRNSAdditional Listing
23rd Dec 20117:00 amRNSPDMR Shareholding
1st Dec 201112:57 pmRNSTotal Voting Rights
28th Nov 201111:47 amRNSDirector/PDMR Shareholding
25th Nov 20115:49 pmRNSHolding(s) in Company
21st Nov 20113:40 pmRNSDirector/PDMR Shareholding
11th Nov 20113:12 pmRNSDirector/PDMR Shareholding
1st Nov 20115:05 pmRNSTotal Voting Rights
1st Nov 20115:03 pmRNSDirector/PDMR Shareholding
27th Oct 20113:32 pmRNSDirector/PDMR Shareholding
21st Oct 201111:32 amRNSResult of AGM
21st Oct 20117:01 amRNSBoard Appointments
21st Oct 20117:00 amRNSAGM Statement
17th Oct 20113:48 pmRNSPDMR Shareholding
3rd Oct 20117:00 amRNSTotal Voting Rights
27th Sep 201110:38 amRNSPDMR Shareholding
23rd Sep 20113:28 pmRNSAnnual Financial Report
15th Sep 20112:42 pmRNSAdditional Listing
31st Aug 20117:00 amRNSPDMR Shareholding
19th Aug 20117:00 amRNSNotification of Results
12th Aug 20117:00 amRNSHolding(s) in Company
8th Aug 20117:00 amRNSHolding(s) in Company
28th Jul 201110:53 amRNSPDMR Shareholding
15th Jul 20117:00 amRNSYear-end Trading Update
1st Jul 20119:15 amRNSTotal Voting Rights
28th Jun 20111:10 pmRNSPDMR Shareholding
16th Jun 20113:19 pmRNSHolding(s) in Company
1st Jun 201110:27 amRNSTotal Voting Rights
27th May 20119:24 amRNSAdditional Listing
24th May 20117:00 amRNSAcquisition
11th May 20118:00 amRNSDirector's Dealings
4th May 20112:27 pmRNSPDMR Shareholding
3rd May 20114:15 pmRNSTotal Voting Rights
5th Apr 20115:05 pmRNSHolding(s) in Company
4th Apr 201112:41 pmRNSTotal Voting Rights
30th Mar 20114:28 pmRNSHalf Yearly Report
25th Mar 20114:59 pmRNSPDMR Shareholding
21st Mar 20115:34 pmRNSDirector/PDMR Shareholding
11th Mar 201112:24 pmRNSDirector's Dealings
8th Mar 20117:00 amRNSHalf Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.